SK282768B6 - D-Manitol, spôsob jeho prípravy a kompozícia s jeho obsahom - Google Patents

D-Manitol, spôsob jeho prípravy a kompozícia s jeho obsahom Download PDF

Info

Publication number
SK282768B6
SK282768B6 SK1432-98A SK143298A SK282768B6 SK 282768 B6 SK282768 B6 SK 282768B6 SK 143298 A SK143298 A SK 143298A SK 282768 B6 SK282768 B6 SK 282768B6
Authority
SK
Slovakia
Prior art keywords
mannitol
crystals
examples
hydrochloride
surface area
Prior art date
Application number
SK1432-98A
Other languages
English (en)
Slovak (sk)
Other versions
SK143298A3 (en
Inventor
Tomohiro Yoshinari
Fritz Schueckler
Norbert Poellinger
Shinji Maegata
Original Assignee
Bayer Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=14109240&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SK282768(B6) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Aktiengesellschaft filed Critical Bayer Aktiengesellschaft
Publication of SK143298A3 publication Critical patent/SK143298A3/sk
Publication of SK282768B6 publication Critical patent/SK282768B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C31/00—Saturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C31/18—Polyhydroxylic acyclic alcohols
    • C07C31/26—Hexahydroxylic alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/74—Separation; Purification; Use of additives, e.g. for stabilisation
    • C07C29/76—Separation; Purification; Use of additives, e.g. for stabilisation by physical treatment
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
  • Chemical Or Physical Treatment Of Fibers (AREA)
  • Steroid Compounds (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
SK1432-98A 1996-04-16 1997-04-14 D-Manitol, spôsob jeho prípravy a kompozícia s jeho obsahom SK282768B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP9440196 1996-04-16
PCT/JP1997/001286 WO1997038960A1 (en) 1996-04-16 1997-04-14 D-mannitol and its preparation

Publications (2)

Publication Number Publication Date
SK143298A3 SK143298A3 (en) 1999-04-13
SK282768B6 true SK282768B6 (sk) 2002-12-03

Family

ID=14109240

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1432-98A SK282768B6 (sk) 1996-04-16 1997-04-14 D-Manitol, spôsob jeho prípravy a kompozícia s jeho obsahom

Country Status (27)

Country Link
US (1) US6503918B2 (de)
EP (1) EP0902777B2 (de)
KR (1) KR20000005486A (de)
CN (1) CN1221398A (de)
AT (1) ATE202768T1 (de)
AU (1) AU718658B2 (de)
BG (1) BG63460B1 (de)
BR (1) BR9708672A (de)
CA (1) CA2251092A1 (de)
CU (1) CU22776A3 (de)
CZ (1) CZ333698A3 (de)
DE (1) DE69705516T3 (de)
DK (1) DK0902777T4 (de)
EA (1) EA000968B1 (de)
ES (1) ES2158540T5 (de)
GR (1) GR3036760T3 (de)
HU (1) HUP9902165A3 (de)
ID (1) ID16566A (de)
IL (1) IL126580A (de)
NO (2) NO311349B1 (de)
NZ (1) NZ332313A (de)
PL (1) PL329614A1 (de)
PT (1) PT902777E (de)
SK (1) SK282768B6 (de)
TR (1) TR199802079T2 (de)
TW (1) TW515787B (de)
WO (1) WO1997038960A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10008506A1 (de) * 2000-02-24 2001-09-13 Bayer Ag Verfahren zur Herstellung von pharmazeutischen Darreichungsformen
FR2807034B1 (fr) † 2000-03-29 2002-06-14 Roquette Freres Mannitol pulverulent et son procede de fabrication
JPWO2002024167A1 (ja) * 2000-09-19 2004-01-29 第一製薬株式会社 医薬組成物
US6855333B1 (en) 2000-10-03 2005-02-15 Mutual Pharmaceutical Co., Inc. Stabilization of solid thyroid drug formulations
US6979462B1 (en) * 2000-10-03 2005-12-27 Mutual Pharmaceutical Co., Inc. Stabilization of solid drug formulations
DE10161402A1 (de) * 2001-12-13 2003-06-18 Merck Patent Gmbh Verfahren zur Herstellung von direkt tablettierbarem beta-Mannit
ES2752452T3 (es) * 2002-05-14 2020-04-06 Dupont Nutrition Usa Inc Composiciones de hidrocoloides de celulosa microcristalinas codesgastadas por atrición y método para su fabricación
US8163797B2 (en) * 2003-12-31 2012-04-24 Actavis Elizabeth Llc Method of treating with stable pravastatin formulation
US7879382B2 (en) * 2005-09-30 2011-02-01 Fmc Corporation Stabilizers and compositions and products comprising same
CA2634232C (en) 2005-12-28 2013-08-20 Takeda Pharmaceutical Company Limited Method of producing solid preparation disintegrating in the oral cavity
ZA200806356B (en) 2006-02-20 2009-11-25 Chugai Pharmaceutical Co Ltd Pharmaceutical composition comprising oseltamivir phosphate
WO2008057267A2 (en) * 2006-10-27 2008-05-15 Fmc Corporation Co-processed microcrystalline cellulose and sugar alcohol as an excipient for tablet formulations
WO2008120548A2 (ja) 2007-03-13 2008-10-09 Dainippon Sumitomo Pharma Co., Ltd. 口腔内崩壊錠
CA2687813C (en) * 2007-05-22 2015-07-07 Ssci, Inc. Preparation of mannitol modification iii
DE102007052070A1 (de) 2007-10-30 2009-05-07 Tiefenbacher Pharmachemikalien Alfred E. Tiefenbacher Gmbh & Co. Kg Candesartancilexetil
CN103429229A (zh) 2010-12-17 2013-12-04 默克专利股份有限公司 可直接压片的δ-甘露糖醇的制备方法
BR112014007366B1 (pt) 2011-10-05 2020-09-15 Dupont Nutrition Usa, Inc Processo para fabricar uma composição estabilizadora compreendendo extrusão em duas etapas, composição estabilizadora de celulose microcristalina e produto alimentício comestível e suspensão industrial compreendendo a mesma
EP2764045B1 (de) 2011-10-05 2017-03-01 FMC Corporation Stabilisatorzusammensetzung aus koattritierter mikrokristalliner cellulose und carboxymethylcellulose, verfahren zu ihrer herstellung und anwendungen davon
BR112014013695B1 (pt) 2011-12-09 2020-11-10 DuPont Nutrition USA, Inc. composição estabilizante de atrito simultâneo tendo uma resistência gel superior, método para a produção da composição estabilizante e alimento
EP3171710A1 (de) * 2014-07-21 2017-05-31 Roquette Frères Zuckerzusammensetzungen zur tablettierung durch direkte kompression
IT201900002857A1 (it) 2019-02-27 2020-08-27 Ntc S R L Procedimento di riempimento di contenitori con una polvere
CN113116843A (zh) * 2021-05-11 2021-07-16 福建海西新药创制有限公司 一种含有缬沙坦的药物组合物及其制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3145146A (en) 1961-10-31 1964-08-18 Warner Lambert Pharmaceutical Modified mannitol for pharmaceutical tablets
DE3245170A1 (de) 1982-12-07 1984-06-07 Merck Patent Gmbh, 6100 Darmstadt Verbesserter sorbit, verfahren zur herstellung und verwendung
FR2571046B1 (fr) 1984-10-03 1987-10-16 Roquette Freres Procede de preparation de mannitol granulaire directement compressible
FR2571045B1 (fr) 1984-10-03 1987-12-11 Roquette Freres Mannitol granulaire directement compressible et son procede de fabrication
JPH0653658B2 (ja) 1984-12-17 1994-07-20 中外製薬株式会社 安定な錠剤の製造法
NO177005C (no) 1988-01-20 1995-07-05 Bayer Ag Analogifremgangsmåte for fremstilling av substituerte pyridiner, samt mellomprodukter til bruk ved fremstillingen
ATE128959T1 (de) 1989-01-24 1995-10-15 Spi Polyols Inc Kryoschützende kristalline sorbitolkügelchen.
ATE99545T1 (de) 1989-03-29 1994-01-15 Takeda Chemical Industries Ltd Zusammensetzung mit einer verbindung der vitamin b-gruppe und ihre herstellung.
US5177080A (en) 1990-12-14 1993-01-05 Bayer Aktiengesellschaft Substituted pyridyl-dihydroxy-heptenoic acid and its salts
HU9203780D0 (en) * 1991-12-12 1993-03-29 Sandoz Ag Stabilized pharmaceutical products of hmg-coa reductase inhibitor and method for producing them
FR2710637B1 (fr) 1993-09-28 1995-12-08 Roquette Freres Mannitol pulvérulent de friabilité modérée et son procédé de préparation.
AUPM411494A0 (en) 1994-02-25 1994-03-24 Central Sydney Area Health Service Method and device for the provocation of upper or lower airway narrowing and/or the induction of sputum
US6235947B1 (en) * 1997-04-14 2001-05-22 Takeda Chemical Industries, Ltd. D-mannitol and its preparation

Also Published As

Publication number Publication date
CN1221398A (zh) 1999-06-30
IL126580A0 (en) 1999-08-17
DE69705516T2 (de) 2002-04-25
BG63460B1 (bg) 2002-02-28
KR20000005486A (ko) 2000-01-25
CA2251092A1 (en) 1997-10-23
CZ333698A3 (cs) 1999-01-13
NZ332313A (en) 2000-02-28
SK143298A3 (en) 1999-04-13
WO1997038960A1 (en) 1997-10-23
EP0902777A1 (de) 1999-03-24
DE69705516T3 (de) 2004-09-30
NO984803D0 (no) 1998-10-15
NO20012249L (no) 1998-12-16
US20020107420A1 (en) 2002-08-08
BG102818A (en) 1999-05-31
TR199802079T2 (xx) 1999-02-22
CU22776A3 (es) 2002-07-24
ES2158540T3 (es) 2001-09-01
NO20012249D0 (no) 2001-05-07
EP0902777B1 (de) 2001-07-04
DK0902777T4 (da) 2004-10-11
ID16566A (id) 1997-10-16
GR3036760T3 (en) 2001-12-31
EA199800888A1 (ru) 1999-04-29
AU718658B2 (en) 2000-04-20
NO311349B1 (no) 2001-11-19
NO984803L (no) 1998-12-16
HUP9902165A2 (hu) 1999-11-29
PT902777E (pt) 2001-11-30
EA000968B1 (ru) 2000-08-28
DK0902777T3 (da) 2001-09-24
ES2158540T5 (es) 2004-11-16
EP0902777B2 (de) 2004-06-16
ATE202768T1 (de) 2001-07-15
US6503918B2 (en) 2003-01-07
AU2522297A (en) 1997-11-07
DE69705516D1 (de) 2001-08-09
PL329614A1 (en) 1999-03-29
IL126580A (en) 2001-08-08
HUP9902165A3 (en) 2001-01-29
BR9708672A (pt) 1999-08-03
TW515787B (en) 2003-01-01

Similar Documents

Publication Publication Date Title
SK282768B6 (sk) D-Manitol, spôsob jeho prípravy a kompozícia s jeho obsahom
US6235947B1 (en) D-mannitol and its preparation
CN1168440C (zh) 左旋多巴/卡比多巴/恩他卡朋药物制剂
JP4773456B2 (ja) 生体利用率を向上させた経口用製剤
LV12731B (en) FORMULA FOR ORAL MEDICINAL PRODUCTS
CN102596184A (zh) 稳定性提高的(z)-2-氰基-3-羟基-丁-2-烯酸-(4’-三氟甲基苯基)-酰胺片剂制剂
CN1684665A (zh) 包含替米沙坦的固体药用制剂
US8846085B2 (en) Method for production of directly compressible ibuprofen formulations
CN1242705A (zh) 含有棒酸盐和一种或多种赋型剂的颗粒剂
JP3126683B2 (ja) Ｄ−マンニトールおよびその製造法
US20010001106A1 (en) D-mannitol and its preparation
CN1805741A (zh) 利用湿法造粒制备的稳定的阿托伐他汀组合物
JP2001114712A (ja) Ｄ−マンニトールおよびその製造法
WO2005020979A1 (en) A process for the preparation of pharmaceutical compositions of nateglinide
EP1142878B1 (de) Moexipril-Magnesium enthaltende Arzneimittel
CN1193906A (zh) 治疗用的泡腾组合物
KR101509489B1 (ko) 발사르탄을 함유하는 고형 경구제형의 제조 방법
JP3232687B2 (ja) イミダプリル含有製剤
EP4321154A1 (de) Tablette aus tolvaptan und mindestens einem bindemittel, die mit sprühgranulation verarbeitet ist
CN115707454A (zh) 缬沙坦口崩片
CA2306633A1 (en) Effervescent base
EA040745B1 (ru) Фармацевтическая композиция, содержащая два различных активных ингредиента, и способ ее получения